Angela Melpignano

790 total citations
24 papers, 358 citations indexed

About

Angela Melpignano is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Angela Melpignano has authored 24 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 14 papers in Genetics and 6 papers in Oncology. Recurrent topics in Angela Melpignano's work include Hemoglobinopathies and Related Disorders (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Blood groups and transfusion (6 papers). Angela Melpignano is often cited by papers focused on Hemoglobinopathies and Related Disorders (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Blood groups and transfusion (6 papers). Angela Melpignano collaborates with scholars based in Italy, Greece and United States. Angela Melpignano's co-authors include Antonio Piga, Giovanni Quarta, Filomena Longo, Gian Luca Forni, Raffaella Origa, Matthew L. Sherman, Kenneth M. Attie, Ersi Voskaridou, Vincenzo Caruso and Silverio Perrotta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Therapeutics.

In The Last Decade

Angela Melpignano

20 papers receiving 352 citations

Peers

Countries citing papers authored by Angela Melpignano

Since Specialization

Citations

This map shows the geographic impact of Angela Melpignano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Melpignano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Melpignano more than expected).

Fields of papers citing papers by Angela Melpignano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Melpignano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Melpignano. The network helps show where Angela Melpignano may publish in the future.

Co-authorship network of co-authors of Angela Melpignano

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Melpignano. A scholar is included among the top collaborators of Angela Melpignano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Melpignano. Angela Melpignano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia 2019 ·Blood ·Antonio Piga, Silverio Perrotta, Maria Rita Gamberini, Ersi Voskaridou, Angela Melpignano, Aldo Filosa, Vincenzo Caruso, Antonello Pietrangelo, Filomena Longo, Immacolata Tartaglione, Caterina Borgna‐Pignatti, Xiaosha Zhang, Abderrahmane Laadem, Matthew L. Sherman, Kenneth M. Attie	82
2	Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP) 2018 ·Annals of Hematology ·Vincenzo Pavone, Anna Mele, (unknown), Giorgina Specchia, Francesco Gaudio, Tommasina Perrone, Patrizio Mazza, Giulia Palazzo, Attilio Guarini, Giacomo Loseto, (unknown), Nicola Cascavilla, Potito Rosario Scalzulli, Angela Melpignano, (unknown), Nicola Di Renzo, Giuseppe Tarantini, Silvana Capalbo	6
3	Luspatercept Increases Hemoglobin, Decreases Transfusion Burden and Improves Iron Overload in Adults with Beta-Thalassemia 2016 ·Blood ·Antonio Piga, Immacolata Tartaglione, Rita Gamberini, Ersi Voskaridou, Angela Melpignano, Paolo Ricchi, Vincenzo Caruso, Antonello Pietrangelo, Xiaosha Zhang, Dawn Wilson, (unknown), Abderrahmane Laadem, Matthew L. Sherman, Kenneth M. Attie	13
4	Response to pomalidomide plus fixed low-dose dexamethasone in a case of secondary plasma cell leukaemia 2015 ·Leukemia Research ·Giuseppe Mele, (unknown), (unknown), (unknown), Angela Melpignano	6
5	Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP) 2015 ·Leukemia Research ·Mario Delia, Paola Carluccio, Caterina Buquicchio, (unknown), (unknown), (unknown), Angela Melpignano, Lorella Melillo, Nicola Cascavilla, Attilio Guarini, Silvana Capalbo, Giuseppe Tarantini, Patrizio Mazza, Vincenzo Pavone, Nicola Di Renzo, Giorgina Specchia	4
6	Luspatercept (ACE-536) Reduces Disease Burden, Including Anemia, Iron Overload, and Leg Ulcers, in Adults with Beta-Thalassemia: Results from a Phase 2 Study 2015 ·Blood ·Antonio Piga, Silverio Perrotta, Maria Rita Gamberini, Ersi Voskaridou, Angela Melpignano, Aldo Filosa, Antonello Pietrangelo, Vincenzo Caruso, Gian Luca Forni, Xiaosha Zhang, (unknown), Dawn Wilson, Abderrahmane Laadem, Matthew L. Sherman, Kenneth M. Attie	7
7	Azacitidine in the front-line treatment of therapy-related myeloid neoplasms: a multicenter case series. 2015 ·PubMed ·Carla Minoia, Nicola Sgherza, Giacomo Loseto, (unknown), Caterina Buquicchio, Francesca Merchionne, (unknown), (unknown), Angela Melpignano, Giuseppe Tarantini, Vincenzo Pavone, Attilio Guarini	6
8	Paralytic ileus following “subcutaneous bortezomib” therapy: focus on the clinical emergency—report of two cases 2015 ·Clinical and Experimental Medicine ·Giuseppe Mele, (unknown), Angela Melpignano, Giovanni Quarta	8
9	Synchronous localizations of Multiple Myeloma in 3 different sites (ethmoidal sinuses, testicles and skin) during the course of Multiple Myeloma (MM) therapy 2015 ·Clinical Lymphoma Myeloma & Leukemia ·Giuseppe Mele, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Maurizio Portaluri, Marianna Criscuolo, Angela Melpignano	0
10	The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a “real life” retrospective multicenter experience of the Rete Ematologica Pugliese (REP) 2015 ·Annals of Hematology ·Patrizio Mazza, Carla Minoia, Angela Melpignano, Giuseppe Polimeno, Nicola Cascavilla, Nicola Di Renzo, Giorgina Specchia	36
11	Pomalidomide and Dexamethasone Association is an Effective Salvage Therapy in Secondary Plasma Cell Leukaemias (PCL) 2015 ·Clinical Lymphoma Myeloma & Leukemia ·Giuseppe Mele, (unknown), (unknown), (unknown), (unknown), Angela Melpignano	0
12	Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis 2014 ·Leukemia Research ·Francesca Merchionne, (unknown), Francesco Gaudio, Carla Minoia, Giorgina Specchia, Attilio Guarini, Giovanni Quarta, Vincenzo Pavone, Angela Melpignano	11
13	Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: A comparison between multiparameter flow cytometry and Wilms’ tumor 1 expression 2014 ·Leukemia Research ·Giovanni Rossi, Angelo Michele Carella, Maria Marta Minervini, Francesco Di Nardo, Chiara de Waure, (unknown), Emanuela Merla, (unknown), Nicola Di Renzo, Angela Melpignano, Silvana Capalbo, (unknown), Giovanni Pisapia, Nicola Cascavilla	23
14	ACE-536 Increases Hemoglobin and Decreases Transfusion Burden and Serum Ferritin in Adults with Beta-Thalassemia: Preliminary Results from a Phase 2 Study 2014 ·Blood ·Antonio Piga, Silverio Perrotta, Angela Melpignano, Caterina Borgna‐Pignatti, Ersi Voskaridou, Vincenzo Caruso, Aldo Filosa, Yeşim Aydınok, (unknown), Dawn Wilson, (unknown), Matthew L. Sherman, Kenneth M. Attie	10
15	Activity and toxicity profiles of the combinations bendamustine–lenalidomide–dexamethasone and bendamustine–bortezomib–dexamethasone for advanced stage multiple myeloma 2013 ·Leukemia & lymphoma ·Giuseppe Mele, (unknown), (unknown), (unknown), Angela Melpignano, (unknown)	4
16	Small-Sized Clone of T Cells in Multiple Myeloma Patient after Auto-SCT: T-LGL Leukemia Type or Clonal T-Cell Aberration? 2013 ·SHILAP Revista de lepidopterología ·Giuseppe Mele, M. Gréco, (unknown), Giacomo Loseto, Angela Melpignano, Salvatore Di Mauro, (unknown)	0
17	Oral Iron Chelator Deferasirox in the Treatment of Secondary Hemochromatosis following Bone Marrow Transplantation in a Patient with Severe Aplastic Anemia 2011 ·Acta Haematologica ·(unknown), Angela Melpignano, Giovanni Quarta	4
18	Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter study 2011 ·European Journal of Echocardiography ·Giorgio Derchi, (unknown), Manuela Balocco, R. Galanello, Patrizio Bina, C. Dessì, Antonio Piga, Guido Di Donato, Maria Domenica Cappellini, Elena Cassinerio, (unknown), Angela Melpignano, Gian Luca Forni	14
19	Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias 2010 ·European Journal of Internal Medicine ·Alberto Fragasso, Angela Ciancio, (unknown), Carlo Gaudiano, Oronzo Scarciolla, (unknown), Marco Francone, M Nardella, Angelo Peluso, Angela Melpignano, (unknown), Giovanni Quarta, (unknown)	33
20	Antibodies to HTLV‐III and the Lymphadenopathy Syndrome in Multitransfused β‐Thalassemia Patients 1985 ·Vox Sanguinis ·Maurizio de Martino, Gianluca Quarta, Angela Melpignano, (unknown), C Vullo, (unknown), Saimot Ag, A Vierucci	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact